feed,title,long_url,short_url
Benzinga,AstraZeneca's Blood Clot Treatment Hits Primary Goal In Rare Blood Disorder Trial,https://benzinga.com/general/biotech/22/09/28893716/astrazenecas-blood-clot-treatment-hits-primary-goal-in-rare-blood-disorder-trial,https://bit.ly/3eXk2LT
